StreetAlpha
13F holdings · Q3 2026

GordonMD Global Investments

Beverely Hills, CA · files as GordonMD Global Investments LP
Know the moment GordonMD Global Investments filesYou follow GordonMD Global Investments An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 2039349

GordonMD Global Investments reported 14 stocks worth $166M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PYXS (21.8%), KYTX (18.5%) and TEVA (9.0%). Compared with Q2 2026, the fund opened new positions in TEVA, TNGX and ADRX, added to PYXS, KYTX and INCY, trimmed VIR, BLCO and TSHA and sold out of RARE, SION and INSM.

Latest filing: what GordonMD Global Investments did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
3 new3 added5 trimmed5 sold outBought about $48.7M · sold about $62.9M
New 3
Added 3
Trimmed 5
Sold out 5
  • Teva Pharmaceutica$16.4M
  • RARE$9.7M
  • SION$6M
  • Crinetics Pharmace$4.8M
  • INSM$3M

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$166M−19.4% vs last quarter
Stocks held143 new · 5 sold out
Top 5 weight60.1%very concentrated
Turnover67%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 4 qtrsHeld
1
PYXS
Pyxis Oncology Inc
$36.2M21.8%15.5M+5.5M (+55%)4 of 4
2
KYTX
Kyverna Therapeutics Inc
$30.7M18.5%4.5M+277K (+7%)4 of 4
3
TEVA
Teva Pharmaceutical Industries Ltd
$15M9.0%380KNew position1 of 4
4
CLDX
Celldex Therapeutics Inc
$9.1M5.5%280KNo change4 of 4
5
TNGX
Tango Therapeutics Inc
$9M5.4%1.9MNew position1 of 4
6
VIR
Vir Biotechnology Inc
$9M5.4%804K−550K (−41%)4 of 4
7
ADRX
Adarx Pharmaceuticals Inc
$9M5.4%450KNew position1 of 4
8
ALLO
Allogene Therapeutics Inc
$8.5M5.1%5.3MNo change3 of 4
9
BLCO
Bausch Plus Lomb Corp
$8.1M4.9%475K−98K (−17%)4 of 4
10
EDIT
Editas Medicine Inc
$8M4.8%3.1MNo change2 of 4
🔒 4 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
TEVA PHARMACEUTICAL INDS LTD
$16.4M2.4M
RARE
Ultragenyx Pharmaceutical in
$9.7M289K
SION
Sionna Therapeutics Inc
$6M136K
CRINETICS PHARMACEUTICALS IN
$4.8M127K
INSM
Insmed Inc
$3M29K

Reported value

last 4 quarters
$139MQ4 '25
$144MQ1 '26
$207MQ2 '26
$166MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

GordonMD Global Investments 13F FAQ

What does GordonMD Global Investments own?

GordonMD Global Investments reported 14 stocks worth $166M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are PYXS (21.8%), KYTX (18.5%) and TEVA (9.0%). The table above lists every position in the filing (the top 10 without an account).

What did GordonMD Global Investments buy and sell in Q3 2026?

Compared with Q2 2026: 3 new positions, 3 added to, 5 trimmed and 5 sold out. New positions include TEVA, TNGX and ADRX. It sold all of RARE, SION and INSM.

When will GordonMD Global Investments file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is GordonMD Global Investments's portfolio worth?

The Q3 2026 filing reports $166M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.